On Wednesday 7 May, the European Federation of Pharmaceutical Industries and Associations (EFPIA) unveiled two reports showing “no shift in access to medicines for millions of Europeans”.
The perpetual inequality of access to medicines requires rapid action by multiple partners to remedy the delays, according to EFPIA.
The W.A.I.T. indicator (https://aeur.eu/f/gp9) provides a comprehensive analysis of 173 new medicines approved between 2020 and 2023. In 2024, based on the EU average...